Figure 6.
CMRO2 changes before and after transplant and compared with healthy controls. (A) CMRO2 changes in adults with SCD before and after HSCT (haplo-BMT). Individual participant changes are shown overlayed on the symbol and line graph, whereas group data are shown in violin plots with the bolded dashed line showing the median and smaller dashed lines showing the upper and lower quartiles for subjects before (blue plot) and after transplant (green plot). (B) Box-and-whisker plots of CMRO2 shown in healthy adults (left; red dots) and in adults with SCD before transplant (middle; blue dots) and 1 year after transplant (right; green dots). CMRO2 does not show significant differences between controls and patients with SCD either before transplant (P = .18) or after transplant (P = .99).

CMRO2 changes before and after transplant and compared with healthy controls. (A) CMRO2 changes in adults with SCD before and after HSCT (haplo-BMT). Individual participant changes are shown overlayed on the symbol and line graph, whereas group data are shown in violin plots with the bolded dashed line showing the median and smaller dashed lines showing the upper and lower quartiles for subjects before (blue plot) and after transplant (green plot). (B) Box-and-whisker plots of CMRO2 shown in healthy adults (left; red dots) and in adults with SCD before transplant (middle; blue dots) and 1 year after transplant (right; green dots). CMRO2 does not show significant differences between controls and patients with SCD either before transplant (P = .18) or after transplant (P = .99).

Close Modal

or Create an Account

Close Modal
Close Modal